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Abstract
The early mammalian embryo utilizes histone H3 lysine 27 trimethylation (H3K27me3) to maintain essential developmental
genes in a repressive chromatin state. As differentiation progresses, H3K27me3 is removed in a distinct fashion to activate
lineage specific patterns of developmental gene expression. These rapid changes in early embryonic chromatin
environment are thought to be dependent on H3K27 demethylases. We have taken a mouse genetics approach to remove
activity of both H3K27 demethylases of the Kdm6 gene family, Utx (Kdm6a, X-linked gene) and Jmjd3 (Kdm6b, autosomal
gene). Male embryos null for active H3K27 demethylation by the Kdm6 gene family survive to term. At mid-gestation,
embryos demonstrate proper patterning and activation of Hox genes. These male embryos retain the Y-chromosome UTX
homolog, UTY, which cannot demethylate H3K27me3 due to mutations in catalytic site of the Jumonji-C domain. Embryonic
stem (ES) cells lacking all enzymatic KDM6 demethylation exhibit a typical decrease in global H3K27me3 levels with
differentiation. Retinoic acid differentiations of these ES cells demonstrate loss of H3K27me3 and gain of H3K4me3 to Hox
promoters and other transcription factors, and induce expression similar to control cells. A small subset of genes exhibit
decreased expression associated with reduction of promoter H3K4me3 and some low-level accumulation of H3K27me3.
Finally, Utx and Jmjd3 mutant mouse embryonic fibroblasts (MEFs) demonstrate dramatic loss of H3K27me3 from promoters
of several Hox genes and transcription factors. Our results indicate that early embryonic H3K27me3 repression can be
alleviated in the absence of active demethylation by the Kdm6 gene family.
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Introduction
The mammalian embryo undergoes drastic changes in cellular
specification and gene expression programs throughout develop-
ment. These changes are facilitated by post-translational mod-
ifications to histones, which provide an epigenetic mechanism to
coordinate initiation and maintenance of lineage specific tran-
scriptional profiles that can be inherited through multiple cellular
divisions. In embryonic stem cells and other pluripotent
progenitors, crucial developmental genes are maintained in
a quiescent state. A bivalent epigenetic signature defines this large
class of genes. These promoters are maintained in a repressive
chromatin state through histone H3 lysine 27 trimethylation
(H3K27me3), however the presence of an active chromatin
modification (H3K4me3) suggests that these genes are poised for
rapid induction as development dictates [1–4]. Bivalent promoters
have been identified in ES cells, the early embryo, lineage
progenitors, and the germline [4–15]. With specification or
differentiation, these bivalent promoters can be resolved to either
a univalent H3K4me3 active state or a H3K27me3 repressed
state. In numerous cell culture model systems, histone demethy-
lases are required to remove H3K27me3 to promote gene
activation, suggesting that H3K27me3 demethylation is essential
in embryonic development [16–30].
H3K27me3 demethylases are members of the KDM6, Jumonji-
C (JmjC) domain family of histone demethylases. The three
KDM6 proteins, JMJD3 (KDM6B, encoded by an autosomal
gene), UTX (KDM6A, X-chromosome), and UTY (Y-chromo-
some), all share a well-conserved JmjC histone demethylation
domain [31]. Within this protein family, JMJD3 and UTX
demethylate H3K27 tri-methyl and di-methyl residues, whereas
human UTY demonstrates greatly reduced catalytic activity
[27,31–34]. Mouse UTY, despite maintaining 82% similarity to
the X-chromosome homologue UTX, does not demethylate
H3K27me3 due to mutations in the catalytic active site of its
JmjC domain [31].
UTX and JMJD3 are individually involved in early embryonic
specification events in cell culture [17–19,22,32], leading to the
hypothesis that H3K27me3 demethylases function in early
embryonic differentiation events. However, mouse mutagenesis
suggests otherwise, as embryos deficient for individual demethy-
lases survive to term. Jmjd32/2 homozygotes exhibit post-natal
lethality due to neonatal respiratory deficits [35]. Utx2/y hemi-
zygous males survive to adulthood and exhibit a normal lifespan
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[31]. In contrast, mutation of the Polycomb Repressive Complex 2
(PRC2) that methylates H3K27 yields precocious expression of
early embryonic developmental genes and arrest in gastrulation
[36–39]. Utx2/2 homozygous females and Utx2;Uty2 hemizygous
males are both mid-gestational lethal with developmental delay
and defects in embryonic heart development [31]. Therefore, the
mid-gestational cardiovascular lethality that is driven by loss of
UTX/UTY is due to demethylase independent function of these
proteins. It is not clear if an early embryonic demethylase
dependent function exists for the KDM6 family as some
redundancy may exist between JMJD3 and UTX.
To study the role of the KDM6 family in early embryonic
development we generated mutations designed to eliminate all
KDM6 H3K27me3 demethylase activity in the developing mouse
embryo. Male Utx2/y;Jmjd32/2 embryos devoid of KDM6
H3K27 demethylation survived to term. Mid-gestational
Utx2/y;Jmjd32/2 embryos appeared phenotypically normal with
characteristic features of embryonic day 10.5 (E10.5) embryos. We
utilized several model systems (embryoid body, retinoic acid,
mouse embryonic fibroblasts) to demonstrate that H3K27me3 can
be removed from the promoters of repressed genes in the absence
of active KDM6 demethylation. We conclude that KDM6
demethylases are not essential for early embryonic development
and that H3K27me3 repression can be alleviated in the absence of
active KDM6 demethylation.
Results
Mouse embryos devoid of KDM6 demethylation survive
to term and display normal early embryonic phenotypes
To remove H3K27 demethylase activity in the mouse embryo
we generated mutant alleles in both Utx and Jmjd3. We previously
characterized the generation of the Utxfl allele that flanks exon 3
with loxP sites [31]. Cre mediated deletion of exon 3 (UtxD)
created a frameshift in the coding sequence and is null for UTX
protein. We now characterize a targeted allele, Jmjd3tm1Mag
(Jmjd3fl) that integrates loxP sites 59 to exon 14 and 39 to exon 20
(Figure S1A). As verified by Southern blotting, PCR genotyping,
and RT-PCR (Figure S1B, S1C, and S1D), Cre mediated deletion
of this portion of the coding sequence (Jmjd3D) removed the JmjC
catalytic H3K27 demethylase domain (Figure S1A). Similar to
published reports, Jmjd3D/D homozygous pups died at birth with
respiratory defects (Figure S1E). Jmjd3D/D homozygous embryos
appeared phenotypically normal at mid-gestation (Figure S1F);
however, several phenotypes manifested late in embryonic de-
velopment which will be described elsewhere. While Jmjd3D/D
homozygous pups were not observed at weaning, they were readily
recovered at E18.5 (Figure 1A).
We next attempted to derive UtxD/y;Jmjd3D/D embryos whereby
all KDM6 H3K27 demethylation is lost, while retaining the
demethylase independent function of wild-type UTY. Similar
to Utx2/y mutation alone [31], both UtxD/y;Jmjd3+/D and
UtxD/y;Jmjd3D/D embryos survived to E18.5 (Figure 1B9 and
1B0). However, there was some reduction in observed UtxD/
y;Jmjd3D/D embryos relative to expected Mendelian frequencies.
Expected genotype frequencies of UtxD/y;Jmjd3D/D embryos were
obtained at E14.5, so some redundancy may exist between Utx
and Jmjd3 in late embryonic viability. At mid-gestation, all
combinations of male Utx and Jmjd3 mutation were largely
indistinguishable from controls (Figure 1D). UtxD/y;Jmjd3D/D
embryos demonstrated normal features of E10.5 embryos, such
as normal size and somite numbers (35-40), prominent fore and
hind-limb buds, and developed branchial arches (including
separation of arch 1 into maxilar and mandibular components,
Figure 1D00). As Utx2/y post-natal lethality is more pronounced on
the C57BL6/J (B6) background [31], we backcrossed UtxD and
Jmjd3D alleles. On a B6 background, UtxD/y;Jmjd3D/D embryos
remained viable at both E14.5 and E18.5 timepoints (Figure 1B90).
Given that deposition of maternal UTX into the Drosophila
embryo contributes to demethylation activity in early development
[40], we tested if deletion of the UTX and JMJD3 maternal pool
enhances mouse phenotypes. Utxfl/D;Jmjd3fl/D;VasaCre female
mice (with oocytes carrying deletion of Utx and Jmjd3) were
crossed with Utxfl/y;Jmjd3fl/D;VasaCre male mice (with sperm
carrying deletion of Utx and Jmjd3) and resulting E10
UtxD/y;Jmjd3D/D embryos (Figure S2A9) had completely recom-
bined Utx and Jmjd3 floxed alleles (Figure S2B) and phenocopied
those derived from Utx+/D;Jmjd3+/D heterozygous mothers
(Figure 1D00).
Utx and Jmjd3 knockout was confirmed by quantitative RT-
PCR (Figure S3A), and at E10.5, UtxD/y;Jmjd3D/D embryos did not
exhibit altered Hox expression levels or elevated global levels of
H3K27me3 (Figure S3B,C,D). Comparative H3K27me3 immu-
nofluorescence of E10.5 Utx+/y;Jmjd3+/D and UtxD/y;Jmjd3D/D
embryos sectioned onto the same slide revealed similar
H3K27me3 levels within heart myocardium (Figure S3E) and
ISL1 positive motor neurons within the proximal spinal chord
(Figure S3F). However, mouse embryonic fibroblasts (MEFs)
derived from these embryos had minor, yet statistically significant
elevations in H3K27me3 levels (Figure S3G,H). Overall, in the
absence of KDM6 H3K27 demethylation, embryos can clearly
survive through gastrulation and exhibit normal patterning at
E10.5. Notably, the phenotypes of UtxD/D;Jmjd3+/D and
UtxD/D;Jmjd3D/D female embryos were similar to UtxD/D homozy-
gous mutation alone, as these embryos are all lethal after E10.5
(Figure 1C) and exhibit similar features of developmental delay
(Figure 1E). Additionally, maternal loss of UTX and JMJD3
demethylation had no contribution to phenotypic severity (Figure
S2A0). Taken together, our data indicate that Utx/Uty are epistatic
to Jmjd3, which primarily functions in later developmental stages.
ES cells with no KDM6 H3K27me3 demethylation have
female specific differentiation defects
We established ES cell differentiation models to study the time-
course of H3K27me3 demethylation in the absence of UTX and
JMJD3. We utilized a CAGGCre-ER transgenic system that will
induce allelic recombination with the addition of tamoxifen [41].
Following 2 days of tamoxifen treatment (+TX), Utxfl/y;
Jmjd3fl/fl;CreER male or Utxfl/fl;Jmjd3fl/fl;CreER female ES lines
demonstrated complete deletion of floxed exons and loss of
Author Summary
H3K27me3 represses developmental genes at initial
embryonic stages. The KDM6 family, comprised of UTX
and JMJD3, are the only known proteins that demethylate
H3K27me3 and they are hypothesized to catalyze the rapid
removal of repressive chromatin in early mammalian
development. However, we report that male embryos
carrying mutations in both Utx and Jmjd3 survive to term
and appear phenotypically normal at mid-gestation. We
utilize several cell culture models to demonstrate that
H3K27me3 is lost from repressed promoters in the absence
of active KDM6 demethylation. Our data indicate that
KDM6 H3K27me3 demethylation is not essential in the
early embryo and that H3K27me3 loss from developmental
genes occurs via novel mechanisms.
H3K27me3 Loss Occurs without KDM6 Activity
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endogenous protein (Figure S4A and S4B). A 140-KD background
band is present in Figure S4B and is not lost in Utxfl/y;
Jmjd3fl/fl;CreER ES +TX. To ensure that this is not an alternative
Utx product, we analyzed its presence in UtxGT1/y ES cells [31],
where any alternative products should be gene trapped. Even
though UtxGT1/y ES cells did trap Utx transcripts preventing
expression across the JmjC domain (Figure S4C) it did not affect
the level of background bands (Figure S4B), indicating that these
are indeed non-specific bands. Furthermore, western blot with
a second, independent UTX antibody produced a clean blot with no
UTX band in Utxfl/y;Jmjd3fl/fl;CreER ES +TX samples (Figure S4D).
We induced embryoid body (EB) differentiation as outlined in
Figure 2A. By 4 days in culture, Utxfl/y;Jmjd3fl/fl;CreER +TX EBs
looked identical to untreated controls (Figure 2B). Utxfl/fl;
Figure 1. Utx and Jmjd3 mutant phenotypes. (A–C) Observed and Expected (in parentheses) numbers of indicated genotypes at embryonic (day
10.5, 14.5 or 18.5) or postnatal (day 25, weaning) timepoints. Data are included for Jmjd3D/D (A), UtxD/y;Jmjd3+/D (B9), UtxD/y;Jmjd3D/D (B0 and B90),
UtxD/D;Jmjd3+/D (C9), and UtxD/D;Jmjd3D/D (C0 and C90) genotypes. Green regions denote viability and red denotes lethality. Mix denotes a mixed
genetic background and B6 has been backcrossed to C57BL6 for .5 generations. Significant deviations from expected allele frequencies as
determined by x2 p-value are: (A) *,0.001, (B) * = 0.005, and (C) *,0.001. (D,E) Embryonic day 10.5 images of (D) male Utx+/y;Jmjd3+/D (D9),
Utx+/y;Jmjd3D/D (D0), UtxD/y;Jmjd3+/D (D90), UtxD/y;Jmjd3D/D (D00) embryos and (E) female UtxD/D (E9) and UtxD/D;Jmjd3D/D (E0) embryos, B6 background.
doi:10.1371/journal.pgen.1004507.g001
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Jmjd3fl/fl;CreER female EBs +TX were small and displayed
a disorganized outer endodermal layer with cells protruding or
sloughing off of the EB (Figure 2B). In contrast to aggregate EB
differentiation, hanging drop EB differentiation utilized smaller
starting ES cell numbers in a defined drop volume, but still
produced similar EB phenotypes (Figure S5A). Embryoid bodies
exhibit a characteristic decrease in global H3K27me3 levels as
differentiation progresses [32,42]. Histones were extracted from
EBs to determine if this process occurs in the absence of UTX and
JMJD3 demethylation. Relative to global levels of H3K27me3 in
ES cells, all EBs, even Utxfl/fl;Jmjd3fl/fl;CreER female EBs +TX
demonstrated a reduction in H3K27me3 (Figure 3C). Fluorescent
quantitative western blotting verified that both male and female +
TX EBs exhibit loss of H3K27me3 levels (Figure S5B,C).
Therefore, early EB differentiation events coincide with down-
regulation of H3K27me3 levels in the absence of all KDM6.
RT-PCR across deleted exons verified that even after 8 days in
culture, wild type Utx and Jmjd3 expression was absent, and Uty
expression was not diminished in TX treated cells (Figure 2D).
Male Utxfl/y;Jmjd3fl/fl;CreER EBs +TX demonstrated normal
activation of primitive ectoderm (Fgf5 expression), mesoderm
(Flk1), and endoderm (Gata6, Figure 2E). In contrast,
Utxfl/fl;Jmjd3fl/fl;CreER female EBs +TX initiated differentiation
and induced primitive ectoderm (Fgf5), but failed to specify meso-
endoderm (Brachyury T, illustrated as T), mesoderm (Flk1), and
endoderm (Gata6, Figure 2E). Utxfl/y;Jmjd3fl/fl;CreER ES +TX
were plated to derive single cell colonies of mutant clones, and
constitutive propagation of this mutant ES line over several weeks
did not affect the ability of the cells to differentiate into EBs (Figure
S5D,E). Overall, the severe deficits of EB differentiation in
Utxfl/fl;Jmjd3fl/fl;CreER +TX cells does not recapitulate the mild
phenotypes of UtxD/D;Jmjd3D/D female embryos (Figure 1E0).
ES cell H3K27me3 removal and gene activation does not
require KDM6 demethylases
To study the role of KDM6 in H3K27me3 demethylation, we
utilized Retinoic acid (+RA) differentiation of ES cells. As
Utxfl/fl;Jmjd3fl/fl;CreER EB +TX appeared capable of initiating
ectoderm specification, RA differentiation towards a neuro-
ectodermal lineage can be studied in this cellular model whereby
all active demethylation by KMD6 members has been removed.
We utilized a 2 day RA differentiation timecourse outlined in
Figure 3A. H3K27me3 ChIP was performed on 4 individual
replicates of WT ES (Utxfl/fl;Jmjd3fl/fl;CreER ES 2TX), KO ES
(Utxfl/fl;Jmjd3fl/fl;CreER ES +TX), WT RA (Utxfl/fl;Jmjd3fl/fl;CreER
RA 2TX), and KO RA (Utxfl/fl;Jmjd3fl/fl;CreER RA +TX). Two
of the 4 replicates of each group were pooled together and the
resulting 2 replicates of each group were subject to high
throughput sequencing. H3K4me3 ChIP-seq was also performed
on 2 replicates of WT RA and KO RA. The model-based analysis
for ChIP-seq (MACS) algorithm identified enrichment peaks of
H3K27me3 and H3K4me3 in each group, and edgeR statistical
analysis software identified genes undergoing H3K27me3 de-
methylation in WT (WT ES vs. WT RA) and KO (KO ES vs. KO
RA) RA differentiation. Overall, 1044 WT ES promoters
(Transcription Start Site: TSS +/21 KB) and 1141 KO ES
promoters demonstrated H3K27me3 peaks. Of these promoters,
945 and 1055 (WT and KO respectively) also had a RA
H3K4me3 peak, signifying that the majority of these promoters
are bivalent.
EdgeR identified 54 WT promoters (from 50 unique genes,
some having alternative promoters) and 109 KO promoters (103
genes) that demonstrated significant loss of H3K27me3 with RA
differentiation (Figure 3B and Table S1) with many genes
overlapping in both datasets. Many Hox genes lost H3K27me3
in both WT and KO RA differentiation. Tracks of H3K27me3
and H3K4me3 ChIP-seq were uploaded into the UCSC genome
browser. With RA differentiation, the proximal Hoxa cluster
(Figure 3C) from Hoxa1 through Hoxa6 demonstrated widespread
loss of H3K27me3 in ES to RA differentiation of both WT and
KO cells. This shift in histone profile correlated with large peaks of
H3K4me3 at proximal Hoxa promoters, demonstrating gene
activation events. Similar large-scale loss of H3K27me3 occurs
from the proximal Hoxb (Hoxb1-Hoxb6), Hoxc (Hoxc4-Hoxc6),
and Hoxd (Hoxd1-Hoxd4) clusters (Figure S6A,B,C). In addition
to Hox genes, many other transcription factors such as Foxa1,
Gata3, Meis2, and Nr2f2 demonstrated loss of promoter
H3K27me3 in KO RA treatment (Figure 4A and Table S1).
H3K27me3 ChIP-qPCR confirmed the loss of H3K27me3 in the
absence of KDM6 demethylation (Figure 4B). Notably, all genes
tested exhibited similar WT and KO loss of H3K27me3 with RA
differentiation. Only Hoxb1 demonstrated a slight, significant
increase in H3K27me3 for KO RA compared to WT RA, but
overall Hoxb1 did exhibit a tremendous decrease in H3K27me3 in
KO RA compared to KO ES. Furthermore, RT-PCR expression
analysis confirmed that the genes demonstrating loss of
H3K27me3 efficiently induced transcriptional activation in RA
KO cells (Figure 4C). Utxfl/fl;Jmjd3fl/fl;CreER ES +TX were plated
to derive single cell colonies of mutant clones, and constitutive
propagation of this mutant ES line over several weeks did not
affect the ability of the cells to activate transcription (Figure S5F).
H3K27 demethylases physically associate with the MLL complex
family of H3K4 methyl-transferases. Two members of this
complex (ASH2L and RBBP5) were expressed at normal levels
in KO cells (Figure S7A). One alternative explanation for loss of
H3K27me3 in the absence of demethylation is that the PRC2
H3K27 methylation complex is down-regulated in differentiated
cells or displaced from targeted promoters in a demethylase
independent manner. While the EZH2 H3K27 methyl-transferase
maintained high expression in RA differentiated cells (Figure S7B),
the protein is displaced from promoters experiencing H3K27me3
loss in the absence of KDM6 demethylation (Figure S7C). In
summary, repressed genes can demonstrate loss of H3K27me3
and initiate expression in the absence of KDM6.
Loss of KDM6 reduces H3K4 methylation and
transcriptional activation in a small subset of H3K4me3
regulated genes
MACs analysis of H3K4me3 ChIP-seq of WT RA and KO RA
cells identified enrichment peaks at 19,140 and 19,367 respective
promoters (TSS +/21 KB). EdgeR comparison of WT RA to KO
RA identified 161 promoters (147 genes) that exhibited significant
(FDR,0.05) reduction in KO H3K4me3 (Figure 5B, Table S2).
The majority of these were small fold changes across a wide range
in overall peak intensity. Of these 161 promoters, only 27 (26
genes) had an ES WT or KO H3K27me3 peak, so the majority of
these genes are not regulated by H3K27 methylation. A few genes
that exhibited KO H3K4me3 reductions and had a H3K27me3
peak are illustrated in the UCSC genome browser image of
Figure 5A. RT-PCR confirmed that several genes with reduced
KO H3K4me3 demonstrated reduced expression (Crabp2, Pax6,
Wnt6, Ccnd2, Figure 5C). Several genes that had been denoted as
experiencing normal H3K27me3 loss and gene activation in KO
RA samples (Hoxb1, Foxa1) experienced normal KO RA
H3K4me3 up-regulation relative to the ES cell state (Figure 5D).
However, ChIP-qPCR did confirm genes identified in ChIP-seq to
be deficient in RA KO H3K4me3 (Crabp2, Wnt6, Figure 5D).
We next examined whether KO RA H3K4me3 affected genes can
H3K27me3 Loss Occurs without KDM6 Activity
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Figure 2. EB differentiation of male and female Utx and Jmjd3 mutant ES cell lines. (A) Utxfl/y;Jmjd3fl/fl;CreER or Utxfl/fl;Jmjd3fl/fl;CreER ES cell
lines were left untreated (2TX) or treated with tamoxifen for 3 days (+TX), then differentiated in aggregate suspension culture (EB). (B) Images of day
4 EBs. (C) Histones were extracted from Utxfl/y;Jmjd3fl/fl;CreER or Utxfl/fl;Jmjd3fl/fl;CreER ES cells (Differentiation ES) or day 4 EBs (Differentiation EB) left
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have associated increases in H3K27me3. ChIP-qPCR of Crabp2
and Wnt6 demonstrated increased KO RA H3K27me3 to ES
comparable levels (Figure 5E).
Meta-analysis of categorized gene subsets reveals low-
level changes in H3K27me3 in the absence of KDM6
demethylation
To better analyze the distribution of H3K27me3 and
K3K4me3 we performed a meta-analysis examining the overall
distribution of these histone modifications across all promoters
with a corresponding MACS peak. These meta analyses
(Figure 6A–G) were plotted with 95% confidence intervals
centered on the mean normalized read counts. ES cells and RA
differentiated cells both had a broad K27me3 distribution across
promoters with a drop-off near the TSS (Figure 6A,B). H3K4me3
enrichment peaked downstream of the TSS (Figure 6C), and there
was very close overlap between WT and KO profiles of both
H3K27me3 and H3K4me3. Genes with significant reductions in
H3K27me3 after RA differentiation, had visible differences in
relative H3K27me3 sequence reads between ES and RA samples
for both WT and KO (Figure 6D). In comparing WT RA to KO
RA, there was very close overlap near the TSS (+/21 KB);
however, upstream of the TSS (22 KB to 21 KB) KO RA
exhibited a significant enrichment in the mean H3K27me3 levels
per gene. Comparison of WT ES to KO ES across this same
region also demonstrated significantly increased H3K27me3 levels
(Figure 6D). Although H3K27me3 was elevated for these KO
promoters, there was a complete overlap in H3K4me3 distribution
(Figure 6E), further supporting data that this gene category was
efficiently activating transcription in KO RA cells (Figure 4C).
Thus, with RA differentiation, KO cells can experience dramatic
reductions in H3K27me3 at specific promoters, and although
there is minor H3K27me3 accumulation upstream of the TSS,
transcription is not compromised.
Meta-analysis of promoters exhibiting H3K4me3 reductions in
KO RA cells verified that this dataset was significantly deficient in
H3K4me3 downstream of the TSS (Figure 6F). The H3K27me3
profile of this dataset revealed that these genes were not subject to
dramatic K3K27me3 loss in WT ES to WT RA differentiation
(Figure 6G). However, there was a small, but significant
H3K27me3 elevation in RA KO relative to RA WT from TSS
+0.5 KB to +1.5 KB. Because identifying a small subset of data
from a graph for statistical analysis amounts to cherry-picking and
is not without bias, we performed a genome-wide comparison of
WT RA to KO RA H3K27me3 levels with edgeR. Genome-wide
cross-comparison of WT RA vs. KO RA did not identify any
promoters (TSS +/21 KB) exhibiting a significant increase in KO
H3K27me3. We also compared all KO RA H3K27me3 MACS
peaks (peak center +/20.5 KB), including those not found at
TSSs, for normalized sequence read enrichment over WT RA.
This analysis identified 74 KO RA H3K27me3 MACS peaks (out
of 4504 total MACS peaks) that were enriched in sequence reads
over WT (Table S3). These peaks resided in varying proximity to
64 unique genes; however, only 7 of these genes demonstrated
compromised transcription based on a reduction in TSS
H3K4me3 levels (Table S3). Overall, with KDM6 loss of
demethylation, a small subset of genes have minor reductions in
H3K4me3 and reduced transcription, and a fraction of these
experience elevated H3K27me3.
MEFs exhibit KDM6 independent loss of H3K27me3 from
promoters
To examine loss of H3K27me3 repression in a differentiated
primary tissue, we utilized mouse embryonic fibroblasts (MEFs).
Primary MEFs were cultured from E13.5 Utxfl/fl;Jmjd3fl/fl;CreER
embryos and treated with tamoxifen as indicated in Figure 7A.
Relative to ES cells, a panel of representative Hox genes (Hoxa3,
Hoxc4, Hoxa13 and Hoxd13) demonstrated elevated expression
levels in MEFs (Figure S8A). Following tamoxifen treatment, the
growth of Utxfl/fl;Jmjd3fl/fl;CreER MEFs slowed dramatically, while
MEFs without Cre continued to proliferate. Regardless,
Utxfl/fl;Jmjd3fl/fl;CreER MEFs +TX largely did not experience
reductions in Hox expression relative to untreated controls
(Figure 7B). Only the most distal genes within the Hox A and D
clusters (Hoxa13 and Hoxd13) demonstrated a slight but
significant reduction in expression with loss of UTX and JMJD3.
Hox H3K27 methylation in Utxfl/fl;Jmjd3fl/fl;CreER MEFs +TX
matched their expression profile as the few distal genes that
demonstrated mild expression deficiencies (Hoxa13 and Hoxd13)
also exhibited a significant increase in H3K27me3 (Figure 7C).
Primary MEFs were also cultured from E13.5 UtxD/y;Jmjd3D/D
embryos to assay function in both establishment and maintenance
of a H3K27 demethylated state. Similar to transient TX induced
KDM6 loss, UtxD/y;Jmjd3D/D MEFs had significantly reduced
expression of more distal Hox genes (Hoxa13, Hoxd13, Figure 7D)
relative to Utx+/y;Jmjd3+/D controls. H3K27me3 ChIP of
UtxD/y;Jmjd3D/D MEFs only revealed some accumulation on
Hoxa13 while other Hox genes were unaffected (Figure 7E).
Notably, several Hox genes demonstrated significant reduction in
H3K27me3 levels relative to ES cells (Hoxa3, Hoxc4, Hoxa6,
Hoxd12) in both control and UtxD/y;Jmjd3D/D MEFs (Figure 7E).
Some proximal Hox genes actually demonstrated an increase in
KO MEF Hox expression (Hoxa3, Hoxc4 and Hoxa6), but this
may be an artifact of the decreased growth rate of these cells as the
H3K27me3 profile of these genes is unaffected. Furthermore,
several other transcription factors (Wnt5a, Zeb2, Smarcd3) also
exhibited near-complete loss of H3K27me3 even though all
KDM6 demethylases had been removed throughout embryonic
development. Notably these genes experience loss of localized
H3K27me3 even though total H3K27me3 protein levels (Figure
S3G,H) and EZH2 levels (Figure S8B,C) were elevated (H3K4me3
levels were not affected, Figure S8C). Therefore, H3K27me3
repressed genes can establish promoter states cleared of this
repressive chromatin in the absence of KDM6 demethylases.
Discussion
A tremendous dichotomy exists in the field of H3K27
demethylases. H3K27me3 results in gene repression throughout
untreated (Tamoxifen 2) or pre-treated with tamoxifen (Tamoxifen +) and western blotted for H3K27me3 relative to total H3 loading control. (D)
Quantitative RT-PCR of Utx, Jmjd3, or Uty from day 0 Utxfl/y;Jmjd3fl/fl;CreER or Utxfl/fl;Jmjd3fl/fl;CreER ES cells (Differentiation 2) or day 8 EBs
(Differentiation +) left untreated (2TX, light grey) or pre-treated with tamoxifen (+TX, black). RT-PCR is across deleted Utx and Jmjd3 exons. N = 3
samples per treatment. All samples are normalized relative to 2TX Differentiation + within individual male or female lines. (E) Quantitative RT-PCR of
Fgf5 (EB day 4), Brachyury T (T, EB day 4), Gata6 (EB day 8), or Flk1 (EB day 8) from Utxfl/y;Jmjd3fl/fl;CreER or Utxfl/fl;Jmjd3fl/fl;CreER ES cells (Diff 2) or
indicated EB timepoint (Diff +) left untreated (2TX, light grey) or pre-treated with tamoxifen (+TX, black). All samples are normalized relative to 2TX
Differentiation + within individual male or female lines. Significant reductions in expression are indicated (T-test p-values * = 0.02, ** = 0.005,
*** = 0.006, N = 3 samples per treatment).
doi:10.1371/journal.pgen.1004507.g002
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Figure 3. Proximal Hox genes demonstrate loss of H3K27me3 with RA treatment in the absence of KDM6 demethylation. (A)
Utxfl/fl;Jmjd3fl/fl;CreER ES cells were untreated (WT) or pre-treated with TX for 3 days (KO), recovered, and differentiated to neuro-ectoderm with 2 days
of retinoic acid treatment. H3K27me3 and H3K4me3 ChIP-seq were performed on D0 ES cells and D2 RA treated cells. (B) The normalized sequence
reads from all promoters (+/21 KB) from ES and RA treated cells were compared by edgeR to identify promoters that exhibit H3K27me3 reductions in
either WT (Utxfl/fl;Jmjd3fl/fl;CreER 2TX) or KO (Utxfl/fl;Jmjd3fl/fl;CreER +TX) cells. The log fold change (logFC) is plotted against the average log counts per
million reads (Average logCPM). In the plot, 54 WT and 109 KO promoters exhibited H3K27me3 reductions with RA treatment (negative logFC, FDR,
0.05, and an identified H3K27me3 MACS peak in ES cells). (C) UCSC genome browser view of ChIP-seq tracks for the Hoxa cluster. Illustrated are Input
(black), WT ES H3K27me3 ChIP (dark green), KO ES H3K27me3 ChIP (dark red), WT RA H3K27me3 ChIP (light green), KO RA H3K27me3 ChIP (light red),
WT RA H3K4me3 ChIP (blue), KO RA H3K4me3 ChIP (orange), and MACS defined enrichment peaks are illustrated as black bars underneath each track.
The RARE region tested by ChIP-qPCR is noted on the bottom.
doi:10.1371/journal.pgen.1004507.g003
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the early embryo, yet enzymes that catalyze its removal are
individually not essential for male embryonic viability. These
findings are unexpected given that numerous genes crucial for
early embryonic gastrulation events [43–52] experience
H3K27me3 de-repression during development [4,53,54] including
but not limited to GATA, TGF-b/BMP, WNT, FGF, and T-box
transcription factor networks. Cell culture model systems
have implicated that UTX and JMJD3 function in activation of
several of these pathways [17–19,22,32]. We now demonstrate
UtxD/y;Jmjd3D/D embryos devoid of all KDM6 demethylation
remarkably survive to term and appear phenotypically normal
at mid-gestation. UtxD/D;Jmjd3D/D embryos (lacking the demethy-
lase independent function of UTY) survive through gastrulation
and albeit smaller in size, can develop E10.5 features. Therefore,
KDM6 is not crucial for alleviating the H3K27me3 repression of
genes needed for early embryonic gastrulation events.
Even within individual cellular and organismal models, several
studies have produced conflicting reports. UTX mediated H3K27
demethylation is reported to function in cellular reprogramming
and germ cell development [55], however surviving Utx mutant
male mice are fertile [31,56]. UTX is reported to be essential for
appropriate expression of germ layer markers in male ES cell
differentiation [19,56], yet differentiation deficits can largely be
rescued by UTY or a catalytically inactive form of UTX [32,57].
UTX is essential for efficient Hox H3K27me3 demethylation and
gene activation [27,29,30,57,58], yet Utx null male ES cells can
largely remove Hox H3K27me3 and demonstrate normal
transcriptional activation [56]. The discrepancies in these reports
may be accounted for by differences in cell type, genetic
background, intrinsic growth differences in ES cell clones,
differential JMJD3 redundancy, or differential UTY expression
[as has been reported [31,32,56,59]. We take advantage of mutant
inducible alleles to enable comparison of control and knockout of
the entire KDM6 family within the same ES cell clone with
identical growth rate and genetic background. Similar to the
normal appearance of mid-gestation UtxD/y;Jmjd3D/D embryos,
KDM6 mutant male ES cells could differentiate normally into all
EB germ layers. Mutant female ES cells null for any KDM6
demethylation demonstrated dramatic reduction in both global
levels of H3K27me3 (with EB differentiation) and local levels of
H3K27me3 from proximal Hox clusters and from promoters of
other transcription factors (with RA differentiation). While there
was a low level significant H3K27me3 accumulation upstream of
these promoters in RA KO cells, these genes were largely cleared
of H3K27me3 and experienced normal transcriptional activation,
similar to findings in Utx male knockout studies alone [56]. Utx
and Jmjd3 mutant MEFs demonstrated mild H3K27me3 accu-
mulation and reduced expression only within the most distal
regions of the Hox cluster. Similarly, Zebrafish UTX loss of
function produces modest deficiencies in distal Hox expression
[27]. EZH2 protein levels were mildly upregulated in Kdm6
mutant MEFs and may account for altered distal Hox
gene regulation. Relative to ES cells, UtxD/y;Jmjd3D/D
MEFs exhibited substantial reductions in promoter H3K27me3
of several Hox genes and developmental transcription factors.
Thus in the absence of KDM6 H3K27 demethylation,
H3K27me3 loss can be both initiated and maintained in
developmental situations.
Our study raises intriguing questions regarding early embryonic
removal of H3K27me3. Thus far, only UTX and JMJD3 have
demonstrated the ability to demethylate H3K27me3. It is unlikely
that another JmjC protein can demethylate H3K27me3. The
KDM7 family including JHDM1D and PHF8 can demethylate
both H3K9 and H3K27 dimethyl residues, but does not
demethylate trimethyl residues [60,61]. The PHF8 active site
cannot sterically accommodate trimethyl residues [62]. In
contrast, UTX positions H3K27me3 farther from the active site
to properly position the larger residue modifications [63].
Furthermore, UTX amino acid Y1135 bonds with a methyl
group of H3K27me3 and is essential for demethylation [31,63].
This residue is not conserved in the KDM7 family. A tyrosine at
this position is conserved for members of the KDM4 family of
H3K9 and H3K36 trimethyl demethylases. However, this family
of proteins has a catalytic core buried within a deep pocket, and
residues downstream of H3K27 do not encode enough flexibility
to fit this modification in the active site [64]. It is possible that
a novel family of proteins may actively demethylate H3K27me3
utilizing distinct chemistry.
Alternatively, H3K27me3 in the early embryo may be replaced
by passive mechanisms, as histones can be turned over multiple
times within each cell cycle [65]. PRC complexes remain bound to
chromatin during DNA replication and associate with the
replication fork in dividing cells to direct methylation of
H3K27me3 on newly incorporated daughter strand histones
[66–68]. Thus, in a passive model for H3K27me3 replacement,
displacement of the PRC2 complex during replication allows for
incorporation of un-methylated H3K27. In a similar fashion,
DNA methylation in the mouse pre-implantation embryo and
germline may be removed via passive replication dependent
mechanisms via displacement of DNA methyl-transferase from
sites of replication [69,70].
The role of the KDM6 family in development is not clear.
Passive H3K27me3 removal may dominate in rapidly dividing
cells such as in the early embryo. Active H3K27me3 demethyla-
tion may prove more essential for rapid response to specific
environmental or developmental cues, particularly in more static
cellular populations. Alternatively, rather than facilitating drastic
gene induction, H3K27 demethylases may act to fine-tune
transcriptional activity to promote accurate robust temporal and
spatial patterns of gene expression. Accordingly, UTY associates
with a wide array of chromatin and transcriptional machinery that
may promote proper gene expression output [31]. In this sense,
Figure 4. Several developmental genes demonstrate loss of H3K27me3 with RA treatment in the absence of KDM6 demethylation.
(A) UCSC genome browser view of Foxa1, Gata3, Meis2, and Nr2f2. Illustrated are Input (black), WT ES H3K27me3 ChIP (dark green), KO ES H3K27me3
ChIP (dark red), WT RA H3K27me3 ChIP (light green), KO RA H3K27me3 ChIP (light red), WT RA H3K4me3 ChIP (blue), KO RA H3K4me3 ChIP (orange),
and MACS defined enrichment peaks are illustrated as black bars underneath each track. Regions tested by ChIP-qPCR are noted on the bottom. (B)
Verification of H3K27me3 loss by ChIP-qPCR. H3K27me3 ChIP of Utxfl/fl;Jmjd3fl/fl;CreER ES cells (dark green and red, Diff 2) or after 2 days of RA
treatment (light green or red, Diff +) left untreated (green) or pre-treated with tamoxifen (red). An IgG control ChIP is illustrated as white bars.
Quantitative PCR of a H3K27me3 negative locus (Slc2a8 promoter, Neg) was utilized for comparison to the Hox A cluster retinoic acid response
element (RARE), Hoxb1, Hoxc4, Hoxa6, Foxa1, Gata3, Meis2, and Nr2f2 promoters. N = 4 samples per treatment. All genes tested exhibited
demethylation in both WT and KO cells, with only Hoxb1 demonstrating a slight, but significant increase in KO RA treatment (p-value = 0.03). (C)
Quantitative RT-PCR of Utx, Jmjd3, and indicated Hox genes, Foxa1, Meis2, and Nr2f2 from Utxfl/fl;Jmjd3fl/fl;CreER ES cells (Diff 2) or after 2 days of RA
treatment (Diff +) left untreated (2TX, light grey) or pre-treated with tamoxifen (+TX, black). N = 3 samples per treatment. All samples are normalized
relative to 2TX Differentiation + RA treatment. No genes tested demonstrated significantly reduced expression in KO RA cells.
doi:10.1371/journal.pgen.1004507.g004
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Figure 5. A subset of genes exhibit reduction of H3K4me3 with loss of UTX and JMJD3. (A) UCSC genome browser view of Crabp2, Pax6,
Wnt6, and Ccnd2. Illustrated are Input (black), WT ES H3K27me3 ChIP (dark green), KO ES H3K27me3 ChIP (dark red), WT RA H3K27me3 ChIP (light
green), KO RA H3K27me3 ChIP (light red), WT RA H3K4me3 ChIP (blue), KO RA H3K4me3 ChIP (orange), and MACS defined enrichment peaks are
illustrated as black bars underneath each track. Regions tested by ChIP-qPCR are noted on the bottom. (B) H3K4me3 ChIP-seq was performed on WT
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KDM6 members may encode a reader function to recruit
transcriptional complexes to repressed genes and/or to displace
PRC2 without the need for active demethylation. Point mutagen-
esis in the UTX and JMJD3 catalytic domains further emphasizes
demethylase independent roles for the KDM6 family [32,71,72].
Going forward, genetic experiments analyzing crosstalk between
chromatin modifying factors and structure/function analysis
within the mammalian embryo are required to define specific
function of the KDM6 family in embryonic development.
Materials and Methods
Mice
All mouse experimental procedures were approved by the
University of North Carolina Institutional Animal Care and Use
Committee. The Utxfl allele is described [31]. The Jmjd3tm1Mag
(Jmjd3fl) allele was derived by targeting E14 ES cells. The Jmjd3
targeting construct was generated by BAC recombineering to
insert a LoxP site in intron 13 and a FRT-Neomycin-FRT-LoxP
cassette in intron 20 of Jmjd3. After successful targeting, the
Neomycin cassette was removed by electroporation of a pCAGG-
FLP construct. The resulting Jmjd3+/fl ES cells were injected into
C57BL/6J blastocysts. Resulting chimeras were mated to CD1
females to assess germline transmission, and were maintained on
either a mixed CD1 background or were backcrossed to C57BL/
6J. UtxD and Jmjd3D alleles were generated by crossing floxed
alleles to the VasaCre transgene that restricts Cre activity to the
germline [73]. These progeny were then mated to propagate the
UtxD and Jmjd3D alleles. To generate higher proportions of
desired genotypes in the Utx Jmjd3 genetic interaction cross,
Utx+/D;Jmjd3+/D female mice were mated with either
Utxfl/y;Jmjd3fl/D;VasaCre or Utx+/y;Jmjd3fl/D;VasaCre males. Em-
bryos were PCR genotyped from yolk sac samples for Utx or
Jmjd3 and were sexed by a PCR genotyping scheme to distinguish
Utx from Uty. All primer sequences are listed in Table S4.
Cell culture
Utxfl/fl;Jmjd3fl/fl;CreER and Utxfl/y;Jmjd3fl/fl;CreER ES cell lines
were generated from E3.5 blastocysts in crosses utilizing
CAGGCre-ER transgenic mouse line [41]. ES cells were cultured
as described [36]. ES cells were split off of feeder MEFs and
treated with 1 mg/mL 4-hydroxytamoxifen (4-OHT) for 3 days
and were allowed to recover for 1 day. In EB differentiation
experiments, 106 ES cells were cultured in 10 mL of ES culture
media lacking LIF on agarose coated Petri dishes. Hanging drop
EBs were set up with 25 mL drops of ES cells at a concentration
of 20,000 cells per mL. In RA differentiation experiments, ES
cells were plated following tamoxifen recovery, and the next day
were cultured without LIF in 1 mM Retinoic Acid. E13.5 MEFs
were generated as described [31]. MEFs were passaged 1x and
treated with 0.5 mM 4-OHT for 2 days, then were passaged and
cultured for an additional 3 days.
RT-PCR, western blotting, and ChIP
RNA was isolated with Trizol and cDNA was synthesized with
Multiscribe reverse transcriptase. Gene expression was analyzed
by qRT-PCR (Bio-Rad SsoFast EvaGreen, CFX96 real time
system). All RT-PCR was normalized to Gapdh expression and
graphed relative to control samples. All primer sequences are listed
in Table S4. Nuclear lysates, histone extracts, and western blotting
was performed as described [31] utilizing anti-RBBP5 (Bethyl
Labs A300-109A, 1:5000), anti-ASH2L (Bethyl Labs A300-107A,
1:3000), anti-H3K27me3 (Millipore 07-449, 1:2000), anti-H3
(Abcam ab1791, 1:10,000), anti-GAPDH (Sigma G9545,
1:10000), anti-UTX [29], or anti-UTX (Bethyl Labs A302-
374A, 1:4000) antibodies. ChIP was performed as described [74]
and graphed relative to % of total ChIP input DNA for each
immunoprecipitation. 56106 cells were sonicated by a Branson
Sonifier at 15% duty cycle (0.7 s on 0.3 s off). For some
experiments, chromatin was sonicated in a chilled water bath by
a Bioruptor sonifier on high setting for 30 s with 60 s rest. Rabbit
IgG (Sigma, I5006), anti-H3K27me3 (Abcam ab6002, 2.5 ml),
anti-H3K4me3 (Abcam ab8580, 2 ml), or EZH2 (Cell Signaling
5246, 3 ml) antibodies were used for ChIP. All ChIP primers are
listed in Table S4. Immunofluorescence experiments were
performed as described [31] with anti H3K27me3 (Cell Signaling
9733S, 1:500) or ISL1 (DSHB 39.4D5-S, 1:200)
Preparation of ChIP-seq libraries and data analysis
ChIP DNA and Input DNA were ligated to Truseq adapters as
described [75]. Samples were multiplexed and sequenced with the
HiSeq 2000 Analyzer (UNC High Throughput Sequencing
Facility). The quality of the sequences reads was evaluated with
FastQC (http://www.bioinformatics.babraham.ac.uk/projects/
fastqc/). Reads were then mapped to the B6 genome using Bowtie
(http://bowtie-bio.sourceforge.net/index.shtml). Significant en-
richment (peaks) were called using MACS (http://liulab.dfci.
harvard.edu/MACS/index.html), with the input ChIP-seq datasets
for the background model, on pooled replicates. Peak lists were
filtered using an FDR cutoff of 0.05. We then identified peaks that
were within 1 Kb of transcriptional start sites (TSSs), as annotated
in the UCSC genome browser for mm9. Read counts for
a particular locus were normalized to the total number of sequence
reads generated for each sample. We used edgeR (http://www.
bioconductor.org/packages/2.12/bioc/html/edgeR.html) to deter-
mine if there was a bias in the number of H3K27me3 or H3K4me3
reads at MACS positive promoters between various samples.
Metaplots were drawn using custom Python scripts and R, and t-
tests were performed using the average read count per gene within
the ranges specified in the text. ChIP-seq datasets were submitted to
(Utxfl/fl;Jmjd3fl/fl;CreER 2TX) or KO (Utxfl/fl;Jmjd3fl/fl;CreER +TX) cells treated with RA. The normalized sequence reads from all promoters (+/21 KB) from
RA treated cells were compared by edgeR to identify promoters that exhibit H3K4me3 reductions in KO cells. The log fold change (logFC) is plotted
against the average log counts per million reads (Average logCPM). In the plot, 161 KO promoters exhibited H3K27me3 reductions with RA treatment
(negative logFC, FDR,0.05, and an identified H3K4me3 MACS peak in WT RA cells). (C) Quantitative RT-PCR of Crabp2, Pax6, Wnt6, and Ccnd2 from
Utxfl/fl;Jmjd3fl/fl;CreER ES cells (Diff 2) or after 2 days of RA treatment (Diff +) left untreated (2TX, light grey) or pre-treated with tamoxifen (+TX, black).
N = 3 samples per treatment. All samples are normalized relative to 2TX Differentiation + RA treatment. Significantly reduced expression is
demonstrated (p-vale = *0.01, **0.03, ***0.001, ****0.004). (D) Verification of H3K4me3 reductions in KO RA cells by ChIP-qPCR. H3K4me3 ChIP of
Utxfl/fl;Jmjd3fl/fl;CreER ES cells (dark green, Diff 2) or after 2 days of RA treatment (light green or red, Diff +) left untreated (green) or pre-treated with
tamoxifen (red). An IgG control ChIP is illustrated as white bars. Quantitative PCR of a H3K4me3 negative locus (gene desert region, Neg) was utilized
for comparison to Npm1 (a positive control), genes exhibiting normal KO gene activation (Hoxb1, Foxa1), and genes with reductions in KO H3K4me3
(Crabp2, Wnt6). Only Crabp2 and Wnt6 demonstrated decreases in KO RA treatment (p-value = *0.01, **0.07). (E) H3K27me3 ChIP of Crabp2 and Wnt6
relative to a negative control (Slc2a8). Both genes demonstrated increases in H3K27me3 in RA KO cells (light red bars, p-value = *0.003, **0.03).
doi:10.1371/journal.pgen.1004507.g005
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Figure 6. Meta-analysis of H3K27me3 and H3K4me3 distribution across female KDM6 WT and KO promoters. (A) Meta-analysis plotted
the normalized H3K27me3 sequence reads and corresponding 95% confidence interval for all female KDM6 WT and KO ES promoters with
a H3K27me3 MACS peak against all promoters without a MACS peak. Gene distributions span 22000 base pairs upstream of the transcription start
site (TSS) to +2000 downstream. (B) Normalized H3K27me3 sequence reads for all WT and KO RA promoters with a H3K27me3 MACS peak against all
promoters without a MACS peak. (C) Normalized H3K4me3 sequence reads for all WT and KO RA promoters with a H3K4me3 MACS peak against all
promoters without a MACS peak. (D) Normalized H3K27me3 sequence reads across promoters identified by edgeR to experience H3K27me3 loss with
RA differentiation. ES WT and KO vs. RA WT and KO are illustrated. While there is a large drop-off in both WT and KO RA counts, KO ES and KO RA was
slightly elevated relative to WT ES and WT RA respectively across 21000 to 22000 (Ttest of means for all given promoters, p-value = *0.036, **0.019)
(E) Normalized H3K4me3 sequence reads across promoters identified by edgeR to experience H3K27me3 loss with RA differentiation. RA WT and KO
are illustrated. (F) Normalized H3K4me3 sequence reads across promoters identified by edgeR to experience H3K4me3 loss in KO RA relative to WT
RA. RA WT and KO are illustrated. KO RA is significantly reduced across 0 to +1000 (p-value = *0.009). (G) Normalized H3K27me3 sequence reads
across promoters identified by edgeR to experience H3K4me3 loss in KO RA relative to WT RA. ES WT and KO vs. RA WT and KO are illustrated. KO RA
was significanly elevated relative to WT RA across +500 to +1500 (p-value = *0.040).
doi:10.1371/journal.pgen.1004507.g006
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Figure 7. RT-PCR and H3K27me3 ChIP of Utx and Jmjd3 mutant MEFs. (A) Schematic of MEF TX treatment. (B) Quantitative RT-PCR of
indicated genes from Utxfl/fl;Jmjd3fl/fl;CreER mouse embryonic fibroblasts (MEFs) left untreated (2TX, light grey) or pre-treated with TX (+TX, black).
Significant reductions in Hox expression are indicated (T-test p-value * = 0.05, ** = 0.02, N = 3 samples per treatment). (C) H3K27me3 ChIP of
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GEO (accession GSE58391: http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc = GSE58391).
Supporting Information
Figure S1 Targeted mutation of Jmjd3. (A) Jmjd3 was targeted
to introduce a LoxP site in intron 13 and another in intron 20. The
FRT site remains after the Neo cassette was removed by FLP
recombinase. A schematic of the JMJD3 protein is illustrated
above to denote the region that will be removed with Cre
recombinase. Splicing from exon 13–21 will introduce a frameshift
and stop codon. (B) Verification of the Jmjd3fl allele. Southern
blotting of WT and targeted Jmjd3+/neofl ES cells with a 39 probe
and XmnI digest demonstrated the expected shift in banding due
to a novel restriction site. The neo cassette was removed from
targeted ES cells by transfection of a Flp recombinase to create
Jmjd3+/fl. (C) Jmjd3fl/fl mice were crossed to a germline Cre
recombinase to create Jmjd3D/D. A PCR genotyping scheme was
designed to distinguish WT, Jmjd3fl, and Jmjd3D alleles in
resulting mice. (D) The Jmjd3 deletion is verified by RT-PCR of
E18.5 whole embryo RNA. Jmjd3D/D embryos lack the exons 14–
17 product and amplification across exons 13–22 produces
a smaller band that corresponds to the expected product lacking
exons 14–20. Therefore, the mutant transcript is stable and is
expected to produce JMJD3 lacking the JmjC histone demethylase
domain. (E) Homozygous Jmjd3 mutant embryos are born, but fail
to breathe as indicated by their blue color. (F) Jmjd3D/D embryos
appear phenotypically normal at E10.5.
(TIF)
Figure S2 Maternal deletion of UTX and JMJD3 does not
enhance embryonic mutant phenotypes. (A) Utxfl/D;Jmjd3fl/D;Va-
saCre female mice (with oocytes carrying deletion Utx and Jmjd3)
were crossed with Utx
fl/y
;Jmjd3fl/D;VasaCre male mice (with sperm
carrying deletion of Utx and Jmjd3) and embryos from the cross
were dissected at E10. UtxD/y;Jmjd3D/D (A9) and UtxD/D;Jmjd3D/D
(A0) embryos from this cross phenocopy embryos derived from
crosses with maternal contribution of UTX and JMJD3 (Figur-
e 1D,E). (B) Genotyping of Utx and Jmjd3 of embryos derived in the
cross in Figure S2A to demonstrate complete recombination of Utx
and Jmjd3 floxed (fl) alleles to deletions (D).
(TIF)
Figure S3 Analysis of mid-gestation UtxD/y;Jmjd3D/D male
embryos. (A,B) Quantitative RT-PCR of KDM6 members (A,
Utx = light grey, Jmjd3 = dark grey, Uty = black) and indicated
Hox genes (B, Hoxc4 = light grey, Hoxa6 = dark grey, Hoxa13 = -
black) in all indicated combinations of E10.5 male Utx and Jmjd3
mutant embryos relative to Utx+/y;Jmjd3+/D controls (N$4 samples
per genotype). (C) Histones were extracted from Utx+/y;Jmjd3+/D or
UtxD/y;Jmjd3D/D embryos and fluorescent western blots are
illustrated for H3K27me3 relative to total H3 loading control.
(D) Quantitation of the western blot in part C, H3k27me3 values
were normalized to total H3 to calculate H3K27me3%. (E)
H3K27me3 immunofluorescence of E10.5 Utx+/y;Jmjd3+/D or
UtxD/y;Jmjd3D/D myocardium. (F) H3K27me3 immunofluores-
cence of E10.5 Utx+/y;Jmjd3+/D or UtxD/y;Jmjd3D/D ISL1 positive
motor neurons in the proximal spinal chord. (G) Histones were
extracted from Utx+/y;Jmjd3+/D or UtxD/y;Jmjd3D/D MEF lines and
fluorescent western blots are illustrated for H3K27me3 relative to
total H4 loading control. (H) Quantitation of western blots for
H3K27me3%, from Utx+/y;Jmjd3+/D (grey) or UtxD/y;Jmjd3D/D
(black) MEFs relative to total H4. Significant increases in protein
levels are indicated (* p-value = 0.05).
(TIF)
Figure S4 Efficiency of tamoxifen CreER induction in Utx and
Jmjd3 floxed ES cell lines. (A) PCR genotyping of a Utxfl/fl;Jmjd3fl/
fl;CreER ES cell line left untreated (2TX) or treated with
tamoxifen for 2 days (+TX) for Utx, Jmjd3, Sex, and presence
of Cre. Controls PCR reactions included are Utx or Jmjd3 floxed
alleles (fl), Utx or Jmjd3 deleted alleles (D), Male DNA (Male),
Female DNA (Female), Cre negative DNA (Neg), Cre positive
DNA (Pos), water (H). (B) Western blot of a Utxfl/y;Jmjd3fl/fl;CreER
ES cell line left untreated (2TX) or treated with tamoxifen for 2
days (+TX) and the UtxGT1/y ES line for UTX (aUTX) or a loading
control (aGAPDH). The UtxGT1/y line should trap all Utx
products. Therefore, the band present in all lanes at 140 KD is
a non-specific band rather than an alternative product because it is
not reduced in the UtxGT1/y sample. (C) RT-PCR for the 3 lines
described in part B across the Utx region deleted by the floxed
allele (Exon 3) and the JmjC domain. Note that all transcripts
containing the JmjC domain are reduced in the UtxGT1/y RNA. (D)
Western blot using a second independent UTX antibody.
(TIF)
Figure S5 Hanging drop EB analysis and constitutive deletion of
Utx and Jmjd3. (A) As an alternative to formation of EBs in mass
culture of ES cells, hanging drop EBs were generated from
a defined cell number in a defined drop volume. (B) Fluorescent
western blot analyzing loss of H3K27me3 with EB differentiation.
H3K27me3 is blotted relative to total H4. (C) Quantification of
the blot in Figure S5B. H3K27me3% is plotted relative to total H4
(D) Differentiation following constitutive long term deletion of Utx
and Jmjd3. Utxfl/y;Jmjd3fl/fl;CreER ES cells were treated with TX
for 3 days, then plated at low density to allow picking of single cell
colonies. A clone of UtxD/y;Jmjd3D/D cells was propagated over 3
weeks and several passages, then differentiated into a typical day 4
EB structure relative to the parental Utxfl/y;Jmjd3fl/fl;CreER line.
(E) Expression analysis of the ES cells (diff 2) and day 8 EBs (diff +
) described in Figure S5D for Utx, Jmjd3, Gata6 (endoderm), and
Flk1 (Mesoderm). (F) Utxfl/fl;Jmjd3fl/fl;CreER ES cells were also
treated with TX to generate single cell clones (as described in
Figure S5D) and UtxD/D;Jmjd3D/D ES cells (Diff 2) were
differentiated with RA for 2 days (diff +) and RT-PCR compared
expression of Utx, Jmjd3, Hoxa1, and Hoxb1 relative to the
parental Utxfl/fl;Jmjd3fl/fl;CreER line.
(TIF)
Figure S6 UCSC genome browser view of Hoxb, Hoxc, and
Hoxd clusters. (A–C) UCSC genome browser view of Hoxb (A),
Utxfl/fl;Jmjd3fl/fl;CreER MEFs left untreated (green) or pre-treated with TX (red). An IgG control ChIP is illustrated as white bars and H3K27me3 ChIP of ES
cells is illustrated as light grey bars. Quantitative PCR of a H3K27me3 negative locus (Slc2a8 promoter, Neg) was utilized for comparison to Hox
promoters. Significant H3K27me3 accumulations of MEF +TX relative to 2TX are indicated (T-test p-value * = 0.01, ** = 0.04, N = 3 samples per
treatment). (D) Quantitative RT-PCR of indicated genes from Utx+/y;Jmjd3+/D (light grey bars) or UtxD/y;Jmjd3D/D MEFs (black bars). Significant
reductions in Hox expression are indicated (T-test p-value * = 0.01, ** = 0.003, N = 3 independent MEF lines per treatment). (E) H3K27me3 ChIP of Utx+/
y;Jmjd3+/D (green bars) or UtxD/y;Jmjd3D/D MEFs (red bars). An IgG control ChIP is illustrated as white bars and H3K27me3 ChIP of ES cells is illustrated
as light grey bars. Quantitative PCR of a H3K27me3 negative locus (Slc2a8 promoter, Neg) was utilized for comparison to promoters of Hox genes and
other indicated transcription factors. Significant H3K27me3 accumulations of UtxD/y;Jmjd3D/D MEFs relative to Utx+/y;Jmjd3+/D MEFs are indicated (T-
test p-value * = 0.02, N = 3 samples per treatment).
doi:10.1371/journal.pgen.1004507.g007
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Hoxc (B), and Hoxd (C), clusters. Illustrated are Input (black),
WT ES H3K27me3 ChIP (dark green), KO ES H3K27me3
ChIP (dark red), WT RA H3K27me3 ChIP (light green), KO
RA H3K27me3 ChIP (light red), WT RA H3K4me3 ChIP
(blue), KO RA H3K4me3 ChIP (orange), and MACS defined
enrichment peaks are illustrated as black bars underneath each
track.
(TIF)
Figure S7 Analysis of MLL and PCR2 complexes in Utx and
Jmjd3 mutant cells. (A) Western blot analyzing levels of MLL
complex members ASH2L and RBBP5 in Utxfl/fl;Jmjd3fl/fl;CreER
ES cells 2TX or +TX. (B) Western blot levels of PRC2 component
EZH2 and RBBP5 in WT ES cells, 2 day RA differentiated ES cells,
or 2 day differentiated EBs. (C) EZH2 ChIP-qPCR of
Utxfl/fl;Jmjd3fl/fl;CreER ES cells (dark green, Diff 2) or after 2 days
of RA treatment (light green or red, Diff +) left untreated (green) or
pre-treated with tamoxifen (red). An IgG control ChIP is illustrated
as white bars. Quantitative PCR of an EZH2 negative locus (Npm1,
Neg) was utilized for comparison to RARE, Hoxa1, Hoxa2, Hoxb1,
Hoxb2, and Hoxd9.
(TIF)
Figure S8 Analysis of Utx and Jmjd3 mutant MEFs. (A) RT-PCR
of Hoxa3, Hoxc4, Hoxa13, or Hoxd13 in ES cells, retinoic acid
treated ES cells, or MEFs. (B) Western blot of EZH2 relative to
RBBP5 loading control from Utx+/y;Jmjd3+/D or UtxD/y;Jmjd3D/D
MEFs. (C) Quantitation of western blots for EZH2 or H3K4me3
from Utx+/y;Jmjd3+/D (grey) or UtxD/y;Jmjd3D/D (black) MEFs.
Significant increases in protein levels are indicated (*p-value = 0.04).
(TIF)
Table S1 Promoters experiencing H3K27me3 loss in ES to RA
differentiation. EdgeR statistical comparison for significant
(FDR,0.05) loss of H3K27me3 normalized sequence reads in
WT RA relative to WT ES (sheet 1) and KO RA relative to KO
ES (Sheet 2) across the TSS +/2 1 KB. Some genes have multiple
alternative promoters, so genes that are duplicated within the list
are highlighted in red. Also denoted is whether the promoter has
a corresponding RA H3K4me3 MACS peak (listed as 1).
(XLSX)
Table S2 Promoters experiencing H3K4me3 reduction in KO
RA differentiation. EdgeR statistical comparison for significant
(FDR,0.05) loss of H3K4me3 normalized sequence reads in KO
RA relative to WT RA across the TSS +/21 KB. Some genes
have multiple alternative promoters, so genes that are duplicated
within the list are highlighted in red. Also denoted is whether the
promoter has a corresponding WT or KO ES H3K27me3 MACS
peak (listed as 1).
(XLSX)
Table S3 KO RA H3K27me3 MACS peaks that have
enrichment in H3K27me3 sequence reads over WT RA. EdgeR
statistical comparison for significant (FDR,0.05) increase in
H3K27me3 normalized sequence reads in KO RA MACS peaks
relative to WT RA across the KO RA peak center +/20.5 KB.
MACS peaks are listed with the nearest neighboring gene. Some
genes are associated with multiple MACS peaks, so genes that are
duplicated within the list are highlighted in red. Also denoted is
whether the promoter of that gene has a corresponding reduction
in KO RA H3K4me3 (listed as 1).
(XLSX)
Table S4 Primers used in the study.
(XLSX)
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